ASTELLAS PHARMA EUROPE LTD.
A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment
- Conditions
- Interventions
- First Posted Date
- 2012-10-24
- Last Posted Date
- 2018-04-23
- Lead Sponsor
- Astellas Pharma Europe Ltd.
- Target Recruit Count
- 568
- Registration Number
- NCT01713426
- Locations
- 🇹🇷
Site 325 Pamukkale University Medical Faculty Hospital, Denizli, Turkey
🇫🇮Site 163 ORTON Invalidisaatio, Helsinki, Finland
🇬🇷Site 203 Aretaieio/Maginio Hospital, Athens, Greece
Vesitirim™ in Men Postmarketing Observational Study
- Conditions
- Interventions
- First Posted Date
- 2012-07-13
- Last Posted Date
- 2013-01-17
- Lead Sponsor
- Astellas Pharma Europe Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT01639794
- Locations
- 🇮🇪
Site: 1 - St James Hopsital, Dublin, Ireland
🇮🇪Site: 3 - Sligo General Hospital, Sligo, Ireland
🇮🇪Site: 4 - Tallaght Hospital, Dublin, Ireland
A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.
- Conditions
- Interventions
- First Posted Date
- 2012-07-11
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Astellas Pharma Europe Ltd.
- Target Recruit Count
- 1887
- Registration Number
- NCT01638000
- Locations
- 🇦🇲
Site: 37404, Yerevan, Armenia
🇦🇲Site: 37402, Yerevan, Armenia
🇦🇹Site: 43013, Linz, Austria
A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time
- Conditions
- Interventions
- First Posted Date
- 2012-06-08
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Astellas Pharma Europe Ltd.
- Target Recruit Count
- 44
- Registration Number
- NCT01614665
- Locations
- 🇫🇷
Site FR32, Paris Cedex 15, France
🇨🇿Site CZ61, Prague 5, Czechia
🇫🇷Site FR33, Bron Cedex, France
An Exploratory Study to Investigate Bladder Contractions in the Storage Phase and Related Bladder Sensations in Healthy Females and Females With Overactive Bladder (OAB) Using High Resolution and Conventional Urodynamics
- Conditions
- Interventions
- First Posted Date
- 2012-02-29
- Last Posted Date
- 2014-10-15
- Lead Sponsor
- Astellas Pharma Europe Ltd.
- Target Recruit Count
- 6
- Registration Number
- NCT01540786
- Locations
- 🇳🇱
Maastricht University Medical Center, Maastricht, Netherlands
A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation
- Conditions
- Interventions
- First Posted Date
- 2011-06-10
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Astellas Pharma Europe Ltd.
- Target Recruit Count
- 52
- Registration Number
- NCT01371331
- Locations
- 🇩🇪
Site 30, Heidelberg, Germany
🇩🇪Site 31, Hannover, Germany
🇫🇷Site: 60, Bron Cedex, France
A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients
- Conditions
- Interventions
- First Posted Date
- 2011-06-10
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Astellas Pharma Europe Ltd.
- Target Recruit Count
- 47
- Registration Number
- NCT01371344
- Locations
- 🇧🇪
Site BE40 Clinique Univ. Saint Luc, Brussels, Belgium
🇫🇷Site FR60 Groupement Hospitalier EST, Bron, France
🇩🇪Site DE31 Kliniken der Medizinischen Hoc, Hannover, Germany
Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®
- Conditions
- Interventions
- First Posted Date
- 2011-02-11
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Astellas Pharma Europe Ltd.
- Target Recruit Count
- 81
- Registration Number
- NCT01294020
- Locations
- 🇵🇱
Site PL51, Warsaw, Poland
🇫🇷Site FR33, Paris Cedex 15, France
🇩🇪Site DE41, Heidelberg, Germany